SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 203.50-1.6%Nov 25 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: WTDEC who wrote (29004)6/29/1999 11:13:00 PM
From: Henry Niman  Read Replies (2) of 32384
 
Walter, I just heard the tape of Blair's remarks. He was commenting on identification of new targets and mentioned that they would be funding Ron Evan's group for basic research in the orphan nuclear receptor area, with the expectation that LGND would then develop the most promising candidates.

This of course would translate into an off balance sheet, somewhat akin to the joint venture between LGND and AGN, which was an off balance sheet R&D program.

$25 Million will be given to Ron Evans followed by LGND taking on the nuclear hormone receptors of most interest, which of course is the IR technology, and not the STAT technology, which I had speculated about before I heard the tape.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext